October 19, 2023
2 min watch
Save
VIDEO: Dextenza successfully used in cataract surgery patients
Issue: November 10, 2023
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
NEW YORK — In this Healio Video Perspective from OSN New York, John A. Hovanesian, MD, FACS, explains why he uses Dextenza to treat inflammation in most of his cataract surgery patients.
Dextenza (Ocular Therapeutix) is a preservative-free sustained-release formulation of dexamethasone in the form of an intracanalicular insert, which means no eye drops are required.
“Dextenza is something we have used for some time in my practice with great success. Our patients love not having to take drops, and we love knowing that they’re getting the medicine that they need,” Hovanesian said.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Hovanesian reports that he is a consultant and stockholder in Ocular Therapeutix.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.